SOC TELEMED INC (TLMD) Stock Price, Quote, News and Overview
NASDAQ:TLMD - Nasdaq - Common Stock
TLMD Quote, Performance and Key Statistics
3
0 (0%)
The current stock price of TLMD is 3 null. In the past month the price increased by 3.45%. In the past year, price decreased by -56.65%.
TLMD Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CI | THE CIGNA GROUP | 10.97 | 82.08B | ||
| CVS | CVS HEALTH CORP | 11.71 | 79.88B | ||
| LH | LABCORP HOLDINGS INC | 17.15 | 20.84B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.1 | 19.12B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 13.74 | 13.55B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 148.77 | 12.18B | ||
| DVA | DAVITA INC | 14.99 | 11.68B | ||
| HIMS | HIMS & HERS HEALTH INC | 112 | 10.77B | ||
| CHE | CHEMED CORP | 23.84 | 8.18B | ||
| CRVL | CORVEL CORP | 25.97 | 5.57B | ||
| OPCH | OPTION CARE HEALTH INC | 26.89 | 5.45B | ||
| GH | GUARDANT HEALTH INC | N/A | 5.30B |
Related stock screener links
About TLMD
Company Profile
SOC Telemed, Inc. engages in the provision of acute care telemedicine services and technology to U.S. hospitals and healthcare. The company is headquartered in Herndon, Virginia and currently employs 226 full-time employees. The company went IPO on 2019-12-17. The firm provides technology enabled clinical solutions, which include acute teleNeurology, telePsychiatry, and teleICU. The firm offers technology platform, Telemed IQ that allows hospitals, health systems and other healthcare organizations the ability to provide telemedicine programs either with their its clinical team or in conjunction with its affiliated network of established, board-certified physicians and other provider specialists. Its cloud based Telemed IQ technology platform is an integrated and configurable technology solution that seamlessly combines voice, video, imaging, electronic medical record (EMR) integration, clinical workflow optimization, clinical resource management, analytics, predictive modeling and other reporting tools.
Company Info
SOC TELEMED INC
2411 Dulles Corner Park, Suite 475
Herndon VIRGINIA 20190 US
CEO: John W. Kalix
Employees: 226
Company Website: https://www.soctelemed.com/
Phone: 18664839690.0
SOC TELEMED INC / TLMD FAQ
What is the stock price of SOC TELEMED INC today?
The current stock price of TLMD is 3 null.
What is the ticker symbol for SOC TELEMED INC stock?
The exchange symbol of SOC TELEMED INC is TLMD and it is listed on the Nasdaq exchange.
On which exchange is TLMD stock listed?
TLMD stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for SOC TELEMED INC stock?
12 analysts have analysed TLMD and the average price target is 3.06 null. This implies a price increase of 2% is expected in the next year compared to the current price of 3. Check the SOC TELEMED INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is SOC TELEMED INC worth?
SOC TELEMED INC (TLMD) has a market capitalization of 303.99M null. This makes TLMD a Small Cap stock.
How many employees does SOC TELEMED INC have?
SOC TELEMED INC (TLMD) currently has 226 employees.
What are the support and resistance levels for SOC TELEMED INC (TLMD) stock?
SOC TELEMED INC (TLMD) has a support level at 2.9 and a resistance level at 3.01. Check the full technical report for a detailed analysis of TLMD support and resistance levels.
Is SOC TELEMED INC (TLMD) expected to grow?
The Revenue of SOC TELEMED INC (TLMD) is expected to grow by 61.44% in the next year. Check the estimates tab for more information on the TLMD EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy SOC TELEMED INC (TLMD) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of TLMD, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of TLMD, evaluating the profitability, health, valuation and growth aspects
- SOC TELEMED INC (TLMD) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- SOC TELEMED INC (TLMD) Sales and EPS estimates to see what analysts future expectations are.
- SOC TELEMED INC (TLMD) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- SOC TELEMED INC (TLMD) Insider and Institutional Ownership to learn about the owners and their transactions.
- SOC TELEMED INC (TLMD) Stock Chart to make your own analysis
- SOC TELEMED INC (TLMD) Latest news and press-releases to stay up to date.
Does SOC TELEMED INC (TLMD) stock pay dividends?
TLMD does not pay a dividend.
When does SOC TELEMED INC (TLMD) report earnings?
SOC TELEMED INC (TLMD) will report earnings on 2022-05-11.
What is the Price/Earnings (PE) ratio of SOC TELEMED INC (TLMD)?
SOC TELEMED INC (TLMD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.45).
TLMD Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to TLMD. When comparing the yearly performance of all stocks, TLMD is one of the better performing stocks in the market, outperforming 96.95% of all stocks.
TLMD Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to TLMD. While TLMD seems to be doing ok healthwise, there are quite some concerns on its profitability.
TLMD Financial Highlights
Over the last trailing twelve months TLMD reported a non-GAAP Earnings per Share(EPS) of -2.45. The EPS decreased by -192688.57% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -69.61% | ||
| ROA | -31.66% | ||
| ROE | N/A | ||
| Debt/Equity | 0.41 |
TLMD Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 75% to TLMD. The Buy consensus is the average rating of analysts ratings from 12 analysts.
For the next year, analysts expect an EPS growth of -42.09% and a revenue growth 61.44% for TLMD